Back to results
CompletedPhase 1Phase 2

Intrathecal Trastuzumab for Leptomeningeal Metastases in HER2+ Breast Cancer

NCT01325207

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

University of California San Francisco (UCSF)

San Francisco, California, United States

+7 additional locations

View on ClinicalTrials.gov
Intrathecal Trastuzumab for Leptomeningeal Metastases in HER2+ Breast Cancer — TrialFind